Basic information Safety Supplier Related

JT010

Basic information Safety Supplier Related

JT010 Basic information

Product Name:
JT010
Synonyms:
  • JT010
  • 2-Chloro-N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(3-methoxypropyl)acetamide
  • Acetamide, 2-chloro-N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(3-methoxypropyl)-
  • 2-chloro-N-(4-(4-methoxyphenyl)thiazol-2-yl)-N-(3-methoxypropyl)acetamide
  • JT010,JT-010,TRP Channel,Transient receptor potential channels,inhibit,Inhibitor,JT 010
  • 2-Chloro-N-(4-(4-methoxyphenyl)thiazol-2-yl)-N-(3-methoxypropyl)acetamide , JT010
  • JT010, 10 mM in DMSO
  • JT010 ,E2515
CAS:
917562-33-5
MF:
C16H19ClN2O3S
MW:
354.85
Mol File:
917562-33-5.mol
More
Less

JT010 Chemical Properties

Boiling point:
487.4±55.0 °C(Predicted)
Density 
1.265±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
powder
pka
2.59±0.10(Predicted)
color 
white to beige
More
Less

JT010 Usage And Synthesis

Description

JT010 is a transient receptor potential ankyrin 1 (TRPA1) agonist (EC50 = 0.65 nM in a calcium influx assay). It is selective for TRPA1 over TRP vanilloid 1 (TRPV1), TRPV3, TRPV4, TRP canonical channel 5 (TRPC5), TRP melastatin 2 (TRPM2), and TRPM8 channels at 1 μM.

Uses

JT010 is a potent and selective TRPA1 channel activator (EC50 = 65 nM); activates the TRPA1 channel by covalently and site-selectively binding to Cys621. Exhibits selectivity for TRPA1 over TRPV1, TRPV3, TRPV4, TRPM2, TRPM8, and TRPC5 channels (EC50 values are >1 μM).

Biochem/physiol Actions

JT010 is a non-cytotoxic and highly stable (>90% remains after 2 h in 1 mM DTT or 2-mercaptoethanol) chloroacetamido warhead-carrying thiazole derivative that acts as a potent and TRPA1-selective channel activator via covalent modification of TRPA1 active site Cys621. JT0101 stimulates calcium influx in TRPA1-transfected HEK293 cells in a dose-dependent manner (EC50?= 650 pM) with excellent selectivity over TRPV1, TRPV3, TRPV4, TRPM2, TRPM8, and TRPC5 channels (EC50?>1 μM).

in vivo

JT010 (0.4 mg/kg, i.v., 60 or 5 min prior to left coronary artery occlusion and 5 min prior to onset of the reperfusion) and A-967079 (HY-108463) have small opposing effects on myocardial infarct size in male rats[6].

storage

Store at +4°C

References

[1] JUNICHIRO TAKAYA. A Potent and Site-Selective Agonist of TRPA1[J]. Journal of the American Chemical Society, 2015, 137 50: 15859-15864. DOI: 10.1021/jacs.5b10162

JT010Supplier

Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Tianjin Kailiqi Biotechnology Co., Ltd.
Tel
15076683720
Email
klq@cw-bio.com